Oneness Biotech protects the basic human rights of all employees, customers and stakeholders. We follow the “United Nations Universal Declaration of Human Rights”, the “United Nations Guiding Principles on Business and Human Rights”, the “United Nations Global Compact” and the “ILO Declaration on Fundamental Principles and Rights at Work”, respect internationally recognized basic human rights, abide by the labor laws and regulations of the place of operation, and formulate human rights policies, labor practices commitment, labor practices program and specific management plans.
Oneness Biotech appreciates opinions and ideas from different parties, and provides open and transparent communication channels. We have established an internal complaint hotline and mailbox, and we hold quarterly labor-management meetings. Additionally, when an employees’ probation period ends or when they submit their resignation, appropriate personnel are arranged to have discussions with them. Employees can use different channels to raise concerns about organizational systems and various issues in their work. No complaints were reported in 2024.
An online platform has been established on our website to allow investors, customers, employees, suppliers, communities, and the press to express opinions. In “Investor FAQs”, all communication and feedback since 2020 are disclosed in detail by date and category as part of our commitment to transparency and respecting the views of our various stakeholders. The Company upholds the core culture of constant advancement and ongoing improvement.
Internal communication and complaint channel

The Company follows international standards such as the “UN Guiding Principles on Business and Human Rights” and the “OECD Due Diligence Guidance for Responsible Business Conduct.” The scope of our human rights due diligence includes self-operation (including full-time employees and contracted employees), stakeholders in business-related activities (including contractors, local residents, and clinical trial subjects), and targets of mergers and acquisitions (no mergers and acquisitions in the past three years). To learn more about labor rights management, mitigation, and compensation measures, as well as the effectiveness of implementation in 2024, please click “Learn More” below to read the related content.

※The above content is taken from the ESG Report